Literature DB >> 21036842

Scorpion envenomation among children: clinical manifestations and outcome (analysis of 685 cases).

Mabrouk Bahloul1, Imen Chabchoub, Anis Chaari, Kamilia Chtara, Hatem Kallel, Hassen Dammak, Hichem Ksibi, Hedi Chelly, Noureddine Rekik, Chokri Ben Hamida, Mounir Bouaziz.   

Abstract

Our objective was to characterize both epidemiologically and clinically manifestations after severe scorpion envenomation and to define simple factors indicative of poor prognosis in children. We performed a retrospective study over 13 years (1990-2002) in the medical intensive care unit (ICU) of a university hospital (Sfax-Tunisia). The diagnosis of scorpion envenomation was based on a history of scorpion sting. The medical records of 685 children aged less than 16 years who were admitted for a scorpion sting were analyzed. There were 558 patients (81.5%) in the grade III group (with cardiogenic shock and/or pulmonary edema or severe neurological manifestation [coma and/or convulsion]) and 127 patients (18.5%) in the grade II group (with systemic manifestations). In this study, 434 patients (63.4%) had a pulmonary edema, and 80 patients had a cardiogenic shock; neurological manifestations were observed in 580 patients (84.7%), 555 patients (81%) developed systemic inflammatory response syndrome (SIRS), and 552 patients (80.6%) developed multi-organ failure. By the end of the stay in the ICU, evolution was marked by the death in 61 patients (8.9%). A multivariate analysis found the following factors to be correlated with a poor outcome: coma with Glasgow coma score ≤ 8/15 (odds ratio [OR] = 1.3), pulmonary edema (OR = 2.3), and cardiogenic shock (OR = 1.7). In addition, a significant association was found between the development of SIRS and heart failure. Moreover, a temperature > 39°C was associated with the presence of pulmonary edema, with a sensitivity at 20.6%, a specificity at 94.4%, and a positive predictive value at 91.7%. Finally, blood sugar levels above 15 mmol/L were significantly associated with a heart failure. In children admitted for severe scorpion envenomation, coma with Glasgow coma score ≤ 8/15, pulmonary edema, and cardiogenic shock were associated with a poor outcome. The presence of SIRS, a temperature > 39°C, and blood sugar levels above 15 mmol/L were associated with heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036842      PMCID: PMC2963974          DOI: 10.4269/ajtmh.2010.10-0036

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  50 in total

1.  Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).

Authors:  S S Qureshi; S M Lewis; V A Gant; D Treacher; B H Davis; K A Brown
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  [Health program and use of community health workers: the example of scorpion envenomation in Tunisia].

Authors:  M Njah; A Ben Abdelaziz; M Abdouli; M Zaher; A Garaoui
Journal:  Sante       Date:  2001 Jan-Feb

3.  Increased plasma levels of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha in patients moderately or severely envenomed by Tityus serrulatus scorpion sting.

Authors:  Y D M Fukuhara; M L Reis; R Dellalibera-Joviliano; F Q C Cunha; E A Donadi
Journal:  Toxicon       Date:  2003-01       Impact factor: 3.033

4.  Evidence for a direct action of Tityus serrulatus scorpion venom on the cardiac muscle.

Authors:  A L Teixeira; B F Fontoura; L Freire-Maia; C R Machado; E R Camargos; M M Teixeira
Journal:  Toxicon       Date:  2001-05       Impact factor: 3.033

5.  Epidemiological and clinical aspects of scorpionism by Tityus trivittatus in Argentina.

Authors:  Adolfo R de Roodt; Susana I García; Oscar D Salomón; Liliana Segre; Jorge A Dolab; Raúl F Funes; Ernesto H de Titto
Journal:  Toxicon       Date:  2003-06       Impact factor: 3.033

6.  Effect of age on body distribution of Tityustoxin from Tityus serrulatus scorpion venom in rats.

Authors:  Elzíria A Nunan; Márcio F D Moraes; Valbert N Cardoso; Tasso Moraes-Santos
Journal:  Life Sci       Date:  2003-06-06       Impact factor: 5.037

7.  Antivenom for critically ill children with neurotoxicity from scorpion stings.

Authors:  Leslie V Boyer; Andreas A Theodorou; Robert A Berg; Joanne Mallie; Ariana Chávez-Méndez; Walter García-Ubbelohde; Stephen Hardiman; Alejandro Alagón
Journal:  N Engl J Med       Date:  2009-05-14       Impact factor: 91.245

8.  Relationship between plasmatic levels of various cytokines, tumour necrosis factor, enzymes, glucose and venom concentration following Tityus scorpion sting.

Authors:  G D'Suze; S Moncada; C González; C Sevcik; V Aguilar; A Alagón
Journal:  Toxicon       Date:  2003-03-01       Impact factor: 3.033

9.  Significance of assessment of serum cardiac troponin I and interleukin-8 in scorpion envenomed children.

Authors:  Abdel-Raheem A M Meki; Zeinab M M Mohamed; Hasan M Mohey El-deen
Journal:  Toxicon       Date:  2003-02       Impact factor: 3.033

10.  Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism.

Authors:  Subodh Verma; Andrew Maitland; Richard D Weisel; Shu-Hong Li; Paul W M Fedak; Neil C Pomroy; Donald A G Mickle; Ren-Ke Li; Lawrence Ko; Vivek Rao
Journal:  J Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 5.209

View more
  21 in total

Review 1.  Incidence, mechanisms and impact outcome of hyperglycaemia in severe scorpion-envenomed patients.

Authors:  Mabrouk Bahloul; Olfa Turki; Anis Chaari; Mounir Bouaziz
Journal:  Ther Adv Endocrinol Metab       Date:  2018-05-03       Impact factor: 3.565

2.  Predictive Value of Glycemia and Free Fatty Acid Levels upon Admission of Children with Scorpionism in Egypt.

Authors:  Khaled Abdalla Abd-Elbaseer; Eman Ahmed Abd-Elmawgood; H M Qubaisy; Abdel-Rahman Abdel-Hamed El-Saied; Mohammed A A Abdel Naser; Yaser F Abd-Elraheem
Journal:  Am J Trop Med Hyg       Date:  2022-01-10       Impact factor: 3.707

3.  Echocardiography guided therapy for myocarditis after scorpion sting envenomation.

Authors:  Suresh V Sagarad; Sudha Biradar Kerure; Balaramsingh Thakur; S S Reddy; Balasubramanya K; R M Joshi
Journal:  J Clin Diagn Res       Date:  2013-12-15

4.  NT-proBNP in Myocarditis after a Scorpion Sting Envenomation.

Authors:  Suresh V Sagarad; Balaram Singh Thakur; S S Reddy; Balasubramanya K; R M Joshi; Sudha Biradar Kerure
Journal:  J Clin Diagn Res       Date:  2013-01-01

5.  Endocrinological and biochemical changes of scorpionism in children in Upper Egypt.

Authors:  Ahmed E Ahmed; Khaled A Abdel-Baseer; Khaled Saad; Asmaa F Hassan; Amira A El-Houfey
Journal:  Ther Adv Endocrinol Metab       Date:  2015-10       Impact factor: 3.565

6.  Doxazosin in the treatment of scorpion envenomation.

Authors:  Capan Konca; Mehmet Tekin; Mehmet Turgut
Journal:  Indian J Pediatr       Date:  2014-04-04       Impact factor: 1.967

7.  Echocardiologic evaluation and follow-up of cardiovascular complications in children with scorpion sting in coastal South India.

Authors:  Chandra Mohan Kumar; S V Naveen Prasad
Journal:  Indian J Crit Care Med       Date:  2015-01

8.  Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality.

Authors:  Karina F Zoccal; Carlos A Sorgi; Juliana I Hori; Francisco W G Paula-Silva; Eliane C Arantes; Carlos H Serezani; Dario S Zamboni; Lúcia H Faccioli
Journal:  Nat Commun       Date:  2016-02-23       Impact factor: 14.919

9.  Effects of climate variables on the incidence of scorpion stings in Iran for five years.

Authors:  Ahmad Ghorbani; Behzad Mansouri; Masoumeh Baradaran
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-06-30

10.  Immunomodulatory activity of Tityus serrulatus scorpion venom on human T lymphocytes.

Authors:  Andrea Casella-Martins; Lorena R Ayres; Sandra M Burin; Fabiana R Morais; Juliana C Pereira; Lucia H Faccioli; Suely V Sampaio; Eliane C Arantes; Fabiola A Castro; Luciana S Pereira-Crott
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.